Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The VA Western New York Healthcare System | FED |
| Syracuse VA Medical Center | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The proposed study involves developing and evaluating an interactive, web-based CBT intervention for OEF/OIF Veterans with hazardous or problematic substance use and PTSD symptoms (PTSD or subsyndromal PTSD). The intervention will address the special culture and experiences of the investigators targeted population (OEF/OIF Veterans). The web-based CBT intervention includes 24 modules, to be used across 24 sessions targeting OEF/OIF Veterans with hazardous or problematic substance use and PTSD symptoms. The investigators ask participants to complete 2 sessions per week (one module per session) for 12 weeks. The first 18 modules to be completed across 18 sessions (9 weeks) are considered core modules relevant to all Veterans in the target population. These modules are designed to reduce posttraumatic stress symptoms as well as reduce and prevent the escalation of problematic substance use. The remaining 6 module topics are considered "optional" and are used based on the interest and clinical need of various sub-groups of VA patients. The study includes initial input as well as feedback on a beta version from experts who have worked with OEF/OIF veterans with PTSD and substance abuse problems as well as input/feedback from the target population (the Veterans themselves). In addition to presenting content grounded in evidence-based CBT interventions, the program also employs state of the art technologies to deliver module content grounded in evidence-based learning principles, including Computer-Assisted Instruction, Computer Simulation and other interactive exercises.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Web-based Cognitive Behavioral Treatment | Experimental | Participants who are randomly assigned to the treatment condition will receive the same standard care as those in the control condition and they will also receive access to the web-based CBT intervention. Participants in this condition will be asked to complete 24 CBT sessions, 2 sessions/topics per week for 12 weeks. Participants will be asked to complete the 18 "core modules" of the program during the first 9 weeks of the trial and then to re-visit important modules and complete optional modules of their choice during the final 3 weeks of the trial. |
|
| Treatment as Usual | No Intervention | TAU consists of the usual Veterans Integrated Service Network 2 (VISN) primary care services. As we have described, all of the participants will be recruited from patients presenting for treatment typically for physical complaints in primary care clinics in VA's VISN 2 (Upstate NY). VISN 2 officially practices a co-located, collaborative care model of integrated (behavioral health and physical health) in its primary care clinics. This integrated model has been implemented widely in both VA and non-VA primary care clinics in the United States . |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Web-based Cognitive Behavioral Treatment | Behavioral | Participants in this condition will be asked to complete 24 CBT sessions, 2 sessions/topics per week for 12 weeks. We expect that each session will be approximately 30 minutes in duration. Participants will be asked to complete the 18 "core modules" of the program during the first 9 weeks of the trial and then to re-visit important modules and complete optional modules of their choice during the final 3 weeks of the trial. They can choose to do this using a designated computer in a private room at their local VA or can complete these sessions in the privacy of their own home with their personally-owned computers. Participants can choose to complete each session on any day/time of their choosing in a given week. |
| Measure | Description | Time Frame |
|---|---|---|
| PTSD Symptomatology | Comparing baseline score of the PCL-M to 12 weeks score | 12 weeks |
| PTSD Symptomatology | Comparing baseline score of the PCL-M to score 1 month post-intervention discharge | 1 month post-intervention |
| PTSD Symptomatology | Comparing baseline score of the PCL-M to score 3 months post-intervention | 3 months post-intervention |
| Alcohol and Drug Use | Comparing baseline score of the Timeline Follow-back (TLFB)to 12 weeks score | 12 weeks |
| Alcohol and Drug Use | Comparing baseline TLFB score to score 1 month post-intervention | 1 month post-intervention |
| Alcohol and Drug Use | Comparing baseline TLFB score to score 3 month post-intervention | 3 month post-intervention |
| Quality of Life | Comparing baseline EuroQOl and WHOQOL-Bref scores to scores at 12 weeks | 12 weeks |
| Quality of Life | Comparing baseline EuroQOl and WHOQOL-Bref scores to scores at 1 month post-intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Resiliency and Positive Affect | Comparing baseline Connor-Davidson Resilience Scale (CD-RISC) and the Positive Affect Negative Affect Scale (PANAS)scores to scores at 12 weeks | 12 weeks |
| Resiliency and Positive Affect |
Not provided
Phase 1: Focus Groups
Inclusion Criteria:
Exclusion Criteria:
Phase 2: Feedback Sessions
Inclusion Criteria
At least 18 years of age
An OEF or OIF veteran (verified via CPRS)
Hazardous or harmful substance use as measured by one of the following:
AUDIT-C score of >=3 (for women) or >= 4 (for men) OR
DAST score of >=2 OR
Have exited a controlled environment (e.g., detoxification unit, hospital, or correctional facility) within 30 days of screening AND within 30 days prior to entering the controlled environment report:
i. heavy drinking (>3 drinks for women or > 4 drinks for men on one or more days), or ii.use of any illegal drugs, iii.or misuse of prescription drugs (use in excess of the directions or any non-medical use)
Screen positive on the PC-PTSD (>=2).
Currently receiving primary medical care at a VA Medical Center (verified via CPRS)
Exclusion Criteria:
Phase 3: Randomized Clinical Trial
Inclusion Criteria:
At least 18 years of age
An OEF or OIF veteran (verified via CPRS)
Hazardous or harmful substance use as measured by one of the following:
AUDIT score of >=7 (for women) or >= 8 (for men) OR
DAST score of >=2 OR
Have exited a controlled environment (e.g., detoxification unit, hospital, or correctional facility) within 30 days of screening AND within 30 days prior to entering the controlled environment report:
i. heavy drinking (>3 drinks for women or > 4 drinks for men on1 or more days) or ii. use of any illegal drugs iii. misuse of prescription drugs (use in excess of the directions or any non-medical use)
Determined to have diagnostic-level or PTSD (1 A symptom, 1 B symptom, 3 C symptoms AND 2 D symptoms) or subthreshold PTSD (1 A symptom, 1 B symptom, 3 C symptoms OR 2 D symptoms) on the Clinician Administered PTSD Scale (CAPS).
Currently receiving primary medical care at a VA Medical Center (verified via CPRS)
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kyle Possemato, Ph.D. | Contact | 315-425-4400 | 53551 | kyle.possemato@va.gov |
| Michelle Acosta, Ph.D. | Contact | 212-845-4535 | acosta@ndri.org |
| Name | Affiliation | Role |
|---|---|---|
| Andrew Rosenblum, Ph.D. | National Development and Research Institutes, Inc. | Principal Investigator |
| Stephen Maisto, Ph.D. | Syracuse University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Buffalo VA Medical Center | Recruiting | Buffalo | New York | 14215 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| 1 month post-intervention |
| Quality of Life | Comparing baseline EuroQOl and WHOQOL-Bref scores to scores at 3 months post-intervention | 3 month post-intervention |
| Cost-Effectiveness | Cost-effectiveness of web-based intervention compared to standard care, as measured by the Brief DATCAP, EuroQol EQ5D, and Non-Study Medical and Other Services (NSMS) scales | 12 weeks |
Comparing baseline Connor-Davidson Resilience Scale (CD-RISC) and the Positive Affect Negative Affect Scale (PANAS)scores to scores at 1 month post-intervention
| 1 month post-intervention |
| Resiliency and Positive Affect | Comparing baseline Connor-Davidson Resilience Scale (CD-RISC) and the Positive Affect Negative Affect Scale (PANAS)scores to scores at 3 months post-intervention | 3 months post-intervention |
| Insomnia | Comparing baseline Insomnia Severity Index (ISI)score to score at 12 weeks | 12 weeks |
| Insomnia | Comparing baseline score on the Insomnia Severity Index (ISI) to score at 1 month post-intervention | 1 month post-intervention |
| Insomnia | Comparing baseline score on the Insomnia Severity Index (ISI) to score at 3 month post-intervention | 3 months post-intervention |
| Psychological Distress | Comparing baseline score on the 10-item version of Symptom Checklist-90 (SCL-90) to score at 12 weeks | 12 weeks |
| Psychological Distress | Comparing baseline score on the 10-item version of Symptom Checklist-90 (SCL-90) to score at 1 month post-intervention | 1 month post-intervention |
| Psychological Distress | Comparing baseline score on the 10-item version of Symptom Checklist-90 (SCL-90) to score at 3 months post-intervention | 3 months post-intervention |
| Pain Severity and Pain Interference | Comparing baseline score on the Brief Pain Inventory (BPI) to score at 12 weeks | 12 weeks |
| Pain Severity and Pain Interference | Comparing baseline score on the Brief Pain Inventory (BPI) to score at 1 month post-intervention | 1 month post-intervention |
| Pain Severity and Pain Interference | Comparing baseline score on the Brief Pain Inventory (BPI) to score at 3 months post-intervention | 3 months post-intervention |
| Treatment Satisfaction | As measured using visual analog scales assessing participant's impressions of how useful, interesting, etc. their treatment has been. | 12 weeks |
| Syracuse VA Medical Center | Recruiting | Syracuse | New York | 13210 | United States |
|
| ID | Term |
|---|---|
| D013313 | Stress Disorders, Post-Traumatic |
| ID | Term |
|---|---|
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided